Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Decreases By 34.6%

Edap Tms S.A. (NASDAQ:EDAP) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 26,300 shares, a decrease of 34.6% from the February 28th total of 40,200 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 75,200 shares, the short-interest ratio is presently 0.3 days.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in EDAP. Illumine Investment Management LLC purchased a new stake in Edap Tms during the 4th quarter valued at $50,000. BNP Paribas Financial Markets boosted its holdings in shares of Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares during the last quarter. Jane Street Group LLC increased its holdings in Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares during the last quarter. Millennium Management LLC increased its holdings in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after buying an additional 33,558 shares during the last quarter. Finally, Orion Capital Management LLC raised its position in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares during the period. 62.74% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

EDAP has been the subject of a number of research analyst reports. Piper Sandler dropped their price target on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday. HC Wainwright reaffirmed a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research note on Friday. Finally, StockNews.com started coverage on shares of Edap Tms in a research note on Friday. They issued a “hold” rating for the company.

Edap Tms Stock Down 3.2 %

Shares of Edap Tms stock traded down $0.07 during midday trading on Friday, hitting $2.15. The company had a trading volume of 143,513 shares, compared to its average volume of 86,608. Edap Tms has a 52-week low of $1.96 and a 52-week high of $8.50. The stock has a market capitalization of $79.77 million, a P/E ratio of -3.31 and a beta of 0.37. The company has a 50 day moving average of $2.42 and a 200 day moving average of $2.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts predict that Edap Tms will post -0.6 earnings per share for the current fiscal year.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.